Lazard Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Sell
393,132
-98,742
-20% -$26.7M 0.17% 126
2025
Q4
$123M Buy
491,874
+8,354
+2% +$2.22M 0.21% 109
2025
Q3
$139M Sell
483,520
-505,913
-51% -$136M 0.19% 117
2025
Q2
$260M Buy
989,433
+684,153
+224% +$167M 0.36% 67
2025
Q1
$71M Buy
305,280
+51,330
+20% +$12.5M 0.11% 151
2024
Q4
$58.2M Buy
253,950
+30,325
+14% +$6.96M 0.09% 174
2024
Q3
$50M Sell
223,625
-22,261
-9% -$4.89M 0.07% 200
2024
Q2
$50M Sell
245,886
-1,455,240
-86% -$296M 0.06% 219
2024
Q1
$372M Sell
1,701,126
-119,846
-7% -$26.4M 0.45% 56
2023
Q4
$414M Sell
1,820,972
-391,525
-18% -$82.2M 0.52% 52
2023
Q3
$445M Buy
2,212,497
+200,384
+10% +$42.3M 0.61% 40
2023
Q2
$417M Sell
2,012,113
-50,980
-2% -$9.89M 0.51% 49
2023
Q1
$407M Buy
2,063,093
+281,387
+16% +$57.9M 0.53% 47
2022
Q4
$360M Buy
1,781,706
+1,499,900
+532% +$293M 0.5% 56
2022
Q3
$49.6M Buy
281,806
+15,579
+6% +$3.19M 0.07% 231
2022
Q2
$53.6M Sell
266,227
-80,131
-23% -$17.1M 0.07% 226
2022
Q1
$78.5M Sell
346,358
-895,750
-72% -$211M 0.09% 196
2021
Q4
$335M Sell
1,242,108
-15,899
-1% -$3.94M 0.36% 65
2021
Q3
$304M Sell
1,258,007
-17,424
-1% -$4.39M 0.34% 64
2021
Q2
$302M Sell
1,275,431
-139,337
-10% -$31.7M 0.34% 73
2021
Q1
$310M Sell
1,414,768
-245,905
-15% -$49.3M 0.38% 68
2020
Q4
$290M Buy
1,660,673
+22,203
+1% +$3.84M 0.37% 70
2020
Q3
$265M Buy
1,638,470
+219,807
+15% +$34.8M 0.37% 64
2020
Q2
$202M Sell
1,418,663
-169,500
-11% -$23.5M 0.31% 76
2020
Q1
$172M Sell
1,588,163
-256,187
-14% -$36.9M 0.32% 73
2019
Q4
$268M Buy
1,844,350
+396,916
+27% +$57.3M 0.38% 68
2019
Q3
$209M Sell
1,447,434
-279,489
-16% -$40.8M 0.34% 72
2019
Q2
$257M Buy
1,726,923
+403,262
+30% +$56.3M 0.42% 61
2019
Q1
$174M Buy
1,323,661
+188,123
+17% +$23.2M 0.28% 82
2018
Q4
$123M Buy
1,135,538
+926,302
+443% +$124M 0.23% 99
2018
Q3
$31.2M Sell
209,236
-2,919
-1% -$444K 0.05% 239
2018
Q2
$32.7M Sell
212,155
-25,200
-11% -$3.8M 0.06% 223
2018
Q1
$33M Sell
237,355
-19,501
-8% -$2.86M 0.06% 221
2017
Q4
$35.2M Buy
256,856
+962
+0.4% +$127K 0.06% 218
2017
Q3
$33.2M Sell
255,894
-26,005
-9% -$3.47M 0.06% 213
2017
Q2
$37.3M Sell
281,899
-89,564
-24% -$11M 0.07% 189
2017
Q1
$45.8M Sell
371,463
-103,242
-22% -$12.2M 0.09% 161
2016
Q4
$52.4M Sell
474,705
-66,231
-12% -$7.36M 0.11% 144
2016
Q3
$63.9M Sell
540,936
-41,327
-7% -$4.87M 0.13% 134
2016
Q2
$65.2M Sell
582,263
-168,919
-22% -$18.2M 0.14% 130
2016
Q1
$75.6M Buy
+751,182
New +$72M 0.16% 119
2015
Q4
Sell
-622
Closed -$57K 1130
2015
Q3
$57K Hold
622
﹤0.01% 916
2015
Q2
$64K Sell
622
-191,837
-100% -$20M ﹤0.01% 957
2015
Q1
$20.8M Buy
192,459
+163,081
+555% +$16.8M 0.04% 242
2014
Q4
$2.72M Buy
29,378
+21,635
+279% +$1.91M 0.01% 626
2014
Q3
$676K Buy
7,743
+7,418
+2,282% +$670K ﹤0.01% 722
2014
Q2
$28K Hold
325
﹤0.01% 952
2014
Q1
$27K Sell
325
-32,610
-99% -$2.6M ﹤0.01% 920
2013
Q4
$2.58M Buy
32,935
+6,227
+23% +$531K 0.01% 592
2013
Q3
$2.27M Buy
+26,708
New +$2.25M 0.01% 588

Other funds holding LH

Lazard Asset Management's LH Position: Q1 2026 in Review

Lazard Asset Management reduced its Labcorp (LH) stake by 20% in Q1 2026, selling an estimated $26.7M and leaving 393,132 shares worth $105M. The position accounts for 0.17% of the portfolio, ranked #126.

Lazard Asset Management first reported a position in LH in Q3 2013 and has held it in 50 quarters since. The position peaked at $445M in Q3 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Lazard Asset Management held 393,132 shares of Labcorp worth $105M as of Q1 2026.
  • Lazard Asset Management sold 98,742 Labcorp shares in Q1 2026, an estimated $26.7M.
  • Labcorp made up 0.17% of Lazard Asset Management's portfolio in Q1 2026, its #126 holding.
  • Lazard Asset Management first reported a position in Labcorp in Q3 2013 and has held it in 50 quarters since.
  • Lazard Asset Management's Labcorp position peaked at $445M in Q3 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.